Stoke Therapeutics, Inc. - Common Stock (STOK)

CUSIP: 86150R107

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock
Shares outstanding
57,529,259
Total 13F shares
35,383,061
Share change
+1,129,480
Total reported value
$848,561,802
Price per share
$23.99
Number of holders
91
Value change
+$26,332,046
Number of buys
46
Number of sells
39

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 86150R107?
CUSIP 86150R107 identifies STOK - Stoke Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of STOK - Stoke Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
RTW INVESTMENTS, LP
13F
Company
6.3%
3,644,248
$92,710,000 30 Sep 2021
13F
FMR LLC
13F
Company
4.3%
2,452,868
$62,401,000 30 Sep 2021
13F
Redmile Group, LLC
13F
Company
4.1%
2,381,958
$60,597,000 30 Sep 2021
13F
VANGUARD GROUP INC
13F
Company
3.2%
1,847,615
$47,003,000 30 Sep 2021
13F
BlackRock Finance, Inc.
13F
Company
2.5%
1,413,118
$35,949,000 30 Sep 2021
13F
Cormorant Asset Management, LP
13F
Company
2.2%
1,278,276
$32,519,000 30 Sep 2021
13F
GILDER GAGNON HOWE & CO LLC
13F
Company
2%
1,123,355
$28,578,000 30 Sep 2021
13F
STATE STREET CORP
13F
Company
1.6%
914,671
$23,269,000 30 Sep 2021
13F
FEDERATED HERMES, INC.
13F
Company
1.3%
734,882
$18,696,000 30 Sep 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.63%
363,335
$9,243,000 30 Sep 2021
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.59%
337,582
$8,588,000 30 Sep 2021
13F
Octagon Capital Advisors LP
13F
Company
0.52%
296,822
$7,551,000 30 Sep 2021
13F
Artal Group S.A.
13F
Company
0.43%
250,000
$6,360,000 30 Sep 2021
13F
NORTHERN TRUST CORP
13F
Company
0.32%
186,942
$4,756,000 30 Sep 2021
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.3%
172,749
$4,395,000 30 Sep 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.25%
145,997
$3,715,000 30 Sep 2021
13F
MORGAN STANLEY
13F
Company
0.25%
141,725
$3,606,000 30 Sep 2021
13F
Casdin Capital, LLC
13F
Company
0.21%
120,000
$3,053,000 30 Sep 2021
13F
Tekla Capital Management LLC
13F
Company
0.17%
99,263
$2,525,000 30 Sep 2021
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.14%
82,879
$2,109,000 30 Sep 2021
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.14%
82,800
$2,106,000 30 Sep 2021
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.14%
81,100
$2,063,000 30 Sep 2021
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.14%
80,549
$2,049,000 30 Sep 2021
13F
Nuveen Asset Management, LLC
13F
Company
0.11%
61,829
$1,560,000 30 Sep 2021
13F
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
0.11%
61,031
$1,553,000 30 Sep 2021
13F
Bank of New York Mellon Corp
13F
Company
0.1%
59,937
$1,525,000 30 Sep 2021
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.1%
54,825
$1,395,000 30 Sep 2021
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.09%
53,482
$1,361,000 30 Sep 2021
13F
HighVista Strategies LLC
13F
Company
0.08%
47,594
$1,211,000 30 Sep 2021
13F
NORGES BANK
13F
Company
0.08%
45,200
$1,150,000 30 Sep 2021
13F
ALPS ADVISORS INC
13F
Company
0.08%
45,034
$1,146,000 30 Sep 2021
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.08%
44,719
$1,138,000 30 Sep 2021
13F
SG Americas Securities, LLC
13F
Company
0.07%
41,814
$1,064,000 30 Sep 2021
13F
CITIGROUP INC
13F
Company
0.07%
39,867
$1,014,000 30 Sep 2021
13F
COWEN AND COMPANY, LLC
13F
Company
0.06%
35,899
$913,000 30 Sep 2021
13F
UBS Group AG
13F
Company
0.06%
32,813
$835,000 30 Sep 2021
13F
Rafferty Asset Management, LLC
13F
Company
0.06%
32,515
$827,000 30 Sep 2021
13F
CITADEL ADVISORS LLC
13F
Company
0.05%
29,367
$747,000 30 Sep 2021
13F
TD ASSET MANAGEMENT INC
13F
Company
0.05%
29,114
$741,000 30 Sep 2021
13F
Swiss National Bank
13F
Company
0.05%
28,200
$717,000 30 Sep 2021
13F
DEUTSCHE BANK AG\
13F
Company
0.05%
27,195
$693,000 30 Sep 2021
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.04%
21,048
$535,000 30 Sep 2021
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.04%
20,830
$530,000 30 Sep 2021
13F
LOS ANGELES CAPITAL MANAGEMENT LLC
13F
Company
0.03%
20,087
$511,000 30 Sep 2021
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.03%
18,600
$473,000 30 Sep 2021
13F
RHUMBLINE ADVISERS
13F
Company
0.03%
18,319
$466,000 30 Sep 2021
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.03%
17,300
$440,000 30 Sep 2021
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.03%
16,601
$422,000 30 Sep 2021
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.03%
16,202
$412,179 30 Sep 2021
13F
Birchview Capital, LP
13F
Company
0.03%
15,000
$382,000 30 Sep 2021
13F

Institutional Holders of Stoke Therapeutics, Inc. - Common Stock (STOK) as of Q4 2021

As of 31 Dec 2021, Stoke Therapeutics, Inc. - Common Stock (STOK) was held by 91 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,383,061 shares. The largest 10 holders included Skorpios Trust, RTW INVESTMENTS, LP, FMR LLC, Redmile Group, LLC, VANGUARD GROUP INC, BlackRock Inc., Cormorant Asset Management, LP, GILDER GAGNON HOWE & CO LLC, STATE STREET CORP, and Octagon Capital Advisors LP. This page lists 91 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
89
Q4 2021 holders
91
Holder diff
2
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 Value $ Q4 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.